16 September 2026 note archive · Item
Tandem t:slim X2 (Original Control-IQ — legacy software): review notes
These archived notes document the scope reviewed on 16 September, including source-access limits. They do not cover later changes or newly added records. They are not independent clinical certification or a guarantee that every claim was verified.
Read the item evidence page →Thriving evidence review — 16 September 2026
Record: Tandem Control-IQ
Scope and findings:
- Checked successor Control-IQ+ manufacturer page and older t:connect correction. Kept foundational Control-IQ evidence separate from expanded successor labeling; country-specific installed software and legacy supply not established.
Primary sources checked:
Limits: The review is restricted to the scopes above. Historical efficacy estimates, editorial scoring and country-specific access were not fully reverified unless expressly stated. A manufacturer or conference report retains that evidence level.